These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9471039)

  • 1. Transition zone volume-adjusted prostate-specific antigen value predicts extracapsular carcinoma of the prostate in patients with intermediate prostate-specific antigen levels.
    Kurita Y; Suzuki A; Masuda H; Ushiyama T; Suzuki K; Fujita K
    Eur Urol; 1998; 33(1):32-8. PubMed ID: 9471039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSA value adjusted for the transition zone volume in the diagnosis of prostate cancer.
    Kurita Y; Ushiyama T; Suzuki K; Fujita K; Kawabe K
    Int J Urol; 1996 Sep; 3(5):367-72. PubMed ID: 8886913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml.
    Zlotta AR; Djavan B; Petein M; Susani M; Marberger M; Schulman CC
    J Urol; 1998 Dec; 160(6 Pt 1):2089-95. PubMed ID: 9817330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen (PSA) value adjusted for transition zone volume and free PSA (gamma-seminoprotein)/PSA ratio in the diagnosis of prostate cancer in patients with intermediate PSA levels.
    Kurita Y; Terada H; Masuda H; Suzuki K; Fujita K
    Br J Urol; 1998 Aug; 82(2):224-30. PubMed ID: 9722757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen density adjusted for the transition zone for staging clinically localized prostate cancer in Japanese patients with intermediate serum prostate-specific antigen levels.
    Furuya Y; Ohta S; Sato N; Kotake T; Sugano I; Nagao K; Masai M
    Anticancer Res; 2001; 21(2B):1317-20. PubMed ID: 11396206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the complexed-to-total prostate-specific antigen ratio in predicting the final pathological stage of clinically localized prostate cancer.
    Martínez M; Navarro S; Medina P; Villavicencio H; Rioja L; Solsona E; Estellés A; Aznar J; Jiménez-Cruz JF; España F
    Eur Urol; 2003 Jun; 43(6):609-14. PubMed ID: 12767360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of PSA, free-to-total PSA ratio and PSA density in the prediction of pathologic stage for clinically localized prostate cancer.
    Aslan G; Irer B; Kefi A; Celebi I; Yörükoğlu K; Esen A
    Int Urol Nephrol; 2005; 37(3):511-4. PubMed ID: 16307332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of prostate-specific antigen and prostate-specific antigen density in the staging of patients with cancer of the prostate.
    Wolff JM; Boeckmann W; Effert PJ; Handt S; Jakse G
    Eur Urol; 1996; 30(4):451-7. PubMed ID: 8977066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
    Douglas TH; Morgan TO; McLeod DG; Moul JW; Murphy GP; Barren R; Sesterhenn IA; Mostofi FK
    Cancer; 1997 Jul; 80(1):107-14. PubMed ID: 9210715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of PSA density for the diagnosis of prostatic cancer and for the indication of radical prostatectomy].
    Doublet JD; Ciofu C; Fouret P; Gattegno B; Thibault P
    Prog Urol; 1995 Apr; 5(2):211-9, 220; discussion 219-20. PubMed ID: 7536529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of the serum prostate-specific antigen-alpha 1-antichymotrypsin complex and its density as a predictor for the extent of prostate cancer.
    Hara I; Miyake H; Hara S; Yamanaka N; Ono Y; Eto H; Takechi Y; Arakawa S; Kamidono S
    BJU Int; 2001 Jul; 88(1):53-7. PubMed ID: 11446846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prostate specific antigen and prostate specific antigen density in patients receiving radical prostatectomy.
    Masai M; Ito H; Kotake T; Nagao K
    Int J Urol; 1996 Mar; 3(2):118-23. PubMed ID: 8689505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of prostate volume on the prostate-specific antigen (PSA) level adjusted for the transition zone volume and free-to-total PSA ratio: a prospective study.
    Moon DG; Yu JW; Lee JG; Kim JJ; Koh SK; Cheon J
    BJU Int; 2000 Oct; 86(6):670-4. PubMed ID: 11069374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations.
    Gohji K; Nomi M; Egawa S; Morisue K; Takenaka A; Okamoto M; Ohori M; Fujii A
    Cancer; 1997 May; 79(10):1969-76. PubMed ID: 9149025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml].
    Janane A; Hajji F; Ismail T; Jawad C; Elondo JC; Dakka Y; Ghadouane M; Ameur A; Abbar M; Albouzidi A
    Actas Urol Esp; 2012 Feb; 36(2):93-8. PubMed ID: 22188752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological study of prostate cancer patients who had a serum PSA level of more than 20 ng/ml and were treated by a radical prostatectomy].
    Udo K; Otsubo S; Sakamoto N; Iguchi A
    Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):685-90. PubMed ID: 17682447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative prostate specific antigen and prostate volume are significant predictors of seminal vesicle invasion in patients with prostate cancer.
    Sfoungaristos S; Perimenis P
    Prague Med Rep; 2011; 112(4):263-71. PubMed ID: 22142521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.